Orlistat gains merit in type 2 diabetes mellitus

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.413, 2003-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Orlistat: In the Prevention and Treatment of Type 2 Diabetes Mellitus

By Keating G.M. Jarvis B.

Drugs, Vol. 61, Iss. 14, 2001-01 ,pp. : 2107-2119

Adis International

Access to resources Recommend Favorite

Orlistat in the treatment of Type 2 diabetes mellitus

By Jneidi Muna Kelley David E

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 5, 2002-05 ,pp. : 599-605

Informa Healthcare

Access to resources Recommend Favorite

Economic Evaluation of Orlistat in Overweight and Obese Patients with Type 2 Diabetes Mellitus

By Maetzel A.

PharmacoEconomics, Vol. 21, Iss. 7, 2003-01 ,pp. : 501-512

Adis International

Access to resources Recommend Favorite

Orlistat - a new approach to weight management in type 2 diabetes

Inpharma, Vol. 1, Iss. 1267, 2000-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

The use of orlistat in the treatment of obesity, dyslipidaemia and Type 2 diabetes

By Nelson Robert H Miles John M

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 14, 2005-11 ,pp. : 2483-2491

Informa Healthcare

Access to resources Recommend Favorite